LabXchange Will Provide Virtual Lab Experiences Integrating Digital Instruction With Collaboration and Mentoring Opportunities
Interactive Platform Levels Playing Field for Aspiring Scientists
Amgen Foundation Contributes $6.5 Million as Founding Sponsor
Technology Built on Open-Source edX PlatformsContinue reading
“Connecting Talent with Opportunity” takes on a new meaning with up to ten FREE 30-day Standard Job Postings on the AZBio Career Center.
We’re ramping up for Arizona Bioscience Week. Join us by taking advantage of this special offer for AZBio Member Companies beginning June 1st and ending September 30th, 2018 .
Each time you post a job or upload your resume you will be entered into a drawing for TWO tickets to the 2018 AZBio Awards during Arizona Bioscience Week.
Two tickets will go to the winning job seeker and two to the winning recruiter/hiring manager.
Department of Defense grant aims to target breast cancer that has spread to the bone by re-igniting the body’s own immune systemContinue reading
Tucson, Ariz. – The University of Arizona has licensed two inventions developed in the Department of Chemistry and Biochemistry to startup MCR Therapeutics. The inventors – Drs. Minying Cai and Victor J. Hruby – developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery.Continue reading
From humble roots in antiquity, the scientific method has come to dominate and transform modern society. Our insights into the natural world, from bacteria to black holes, are fruits of the scientific approach to understanding, as are the life-saving medical innovations society relies on.Continue reading
Innovative ‘Phase 0’ clinical trial successful in reaching deadly brain tumorsContinue reading
Events are planned across the nation to engage diverse communities in the national recruitment effort. In Arizona, Banner Health and the University of Arizona Health Sciences have been enrolling volunteers into the program as a National Institutes of Health pilot site since 2017.Continue reading
Salutaris Medical Devices, Inc. announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018.Continue reading
The UA’s focus has been on helping people with chronic pain without using narcotics or other addictive drugs.Continue reading
SenesTech, Inc. (NASDAQ: SNES) announced the issuance of its patent on “REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS.” This intellectual property is a key aspect of ContraPest®, SenesTech’s flagship product that targets the reproductive capabilities of Norway and roof rats . The patent application was filed August 23, 2013, and has been issued on May 3, 2018 with patent number US 9,956,235.
Continue reading
